Primoplex is indicated in the treatment of refractory deficient red cell production anemias. These may include aplastic anemia, myelofibrosis, myelosclerosis, agnogenic myeloid metaplasia, and hypoplastic anemias caused by malignancy or myelotoxic drugs.
Primoplex is indicated in conditions such as chronic infections, extensive surgery, [corticosteroid-induced myopathy, decubitus ulcers, burns] , or severe trauma, which require reversal of catabolic processes or protein sparing effects. These agents are adjuncts to, and not replacements for, conventional treatment of these disorders.
Primoplex (Methenolone Acetate) has been used in certain countries to counteract catabolic states, for example after major trauma.
Primoplex 25 is white tablet coated in a green protective cover that will prevent absorption in the stomach, thus allowing for correct absorption in the lower intestine.